THEOREM GROUP LLC 13G FOR GT BIOPHARMA, INC.

Company

GT Biopharma, Inc.

Filed

November 14, 2017

Accession Number

0000939798-17-000081

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →